Your browser doesn't support javascript.
loading
Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment.
Nik, Maryam Ebrahimi; Momtazi-Borojeni, Amir Abbas; Zamani, Parvin; Navashenaq, Jamshid Gholizadeh; Iranshahi, Mehrdad; Jaafari, Mahmoud Reza; Malaekeh-Nikouei, Bizhan.
Afiliação
  • Nik ME; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Momtazi-Borojeni AA; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Zamani P; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Navashenaq JG; Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Iranshahi M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Jaafari MR; Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Malaekeh-Nikouei B; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
J Cell Physiol ; 234(9): 14721-14733, 2019 Sep.
Article em En | MEDLINE | ID: mdl-30697744
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article